H.R. 1780 · 118th Congress · House

Finn Sawyer Access to Cancer Testing Act

Active· Referred to the Subcommittee on Health.
Introduced
Mar 24, 23
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Finn Sawyer Access to Cancer Testing Act

This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer.

Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.

Action Timeline

6
  1. DEC 17, 2024Committee

    Referred to the Subcommittee on Health.

  2. MAR 31, 2023Committee

    Referred to the Subcommittee on Health.

  3. MAR 24, 2023IntroReferral

    Introduced in House

  4. MAR 24, 2023IntroReferral

    Introduced in House

  5. MAR 24, 2023IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  6. MAR 24, 2023IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committees

4

Health Subcommittee

hswm02

Referred: Dec 17, 2024

Active

Health Subcommittee

hsif14

Referred: Mar 31, 2023

Active

Ways and Means Committee

hswm00

Referred: Mar 24, 2023

Active

Energy and Commerce Committee

hsif00

Referred: Mar 24, 2023

Active